First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults
首次人体研究，旨在评估快速研发的 SARS-CoV-2 治疗性抗体 AOD01 在健康成年人中的安全性、耐受性、药代动力学和药效学
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-022-00681-1
Prativadibhayankaram, Venkateshan S; Lee, Lawrence Soon-U; Lye, David; Xiaoying, Xu; Nellore, Ranjani; Pendharkar, Vishal; Hentze, Hannes; Guan, Siyu; Ayers, Benjamin J; Seah, Shirley G K; Chye, De Hoe; Talib, Najwa S N; Kaliaperumal, Nivashini; Ong, Wei Yee; Wong, Zi Xin; Au, Veonice B; Alok, Anshula; Connolly, John E; Boyd-Kirkup, Jerome D; Ingram, Piers J; Hanson, Brendon J; Ethirajulu, Kantharaj; O'Connell, Damian; Chan, Conrad E Z
